These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Congress works to permit 'biosimilar' drugs very soon. Carroll J Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559 [No Abstract] [Full Text] [Related]
4. SuperGenerics: a better alternative for biogenerics. Charles SA Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591 [No Abstract] [Full Text] [Related]
5. US biotech prepares to fight generic biologics. Reid B Nat Biotechnol; 2002 Apr; 20(4):322. PubMed ID: 11923820 [No Abstract] [Full Text] [Related]
6. Path to approval proves rocky for copycat biodrugs. Wadman M Nature; 2005 Nov; 438(7065):154-5. PubMed ID: 16281004 [No Abstract] [Full Text] [Related]
7. Biotechs go generic: the same but different. Ledford H Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194 [No Abstract] [Full Text] [Related]
8. Current regulatory and legal considerations for follow-on biologics. Kingham RF; Lietzan E Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615 [No Abstract] [Full Text] [Related]
9. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law. Dinh TQ Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027 [No Abstract] [Full Text] [Related]
10. Implementation of the biosimilar pathway: economic and policy issues. Grabowski H; Long G; Mortimer R Seton Hall Law Rev; 2011; 41(2):511-57. PubMed ID: 21739758 [No Abstract] [Full Text] [Related]
13. Data exclusivity for biologics. Grabowski H; Long G; Mortimer R Nat Rev Drug Discov; 2011 Jan; 10(1):15-6. PubMed ID: 21193860 [No Abstract] [Full Text] [Related]
14. Epo, by any other name. Nature; 2007 Sep; 449(7160):259. PubMed ID: 17882170 [No Abstract] [Full Text] [Related]
15. Recommendations and requirements for the design of bioanalytical testing used in comparability studies for biosimilar drug development. Cai XY; Gouty D; Baughman S; Ramakrishnan M; Cullen C Bioanalysis; 2011 Mar; 3(5):535-40. PubMed ID: 21388266 [TBL] [Abstract][Full Text] [Related]
16. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
17. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1. Kuhrt K; Chace-Ortiz M IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217 [TBL] [Abstract][Full Text] [Related]